BRACONI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 10.331
EU - Europa 8.015
AS - Asia 3.845
SA - Sud America 671
Continente sconosciuto - Info sul continente non disponibili 267
AF - Africa 195
OC - Oceania 16
Totale 23.340
Nazione #
US - Stati Uniti d'America 10.170
GB - Regno Unito 1.966
IT - Italia 1.551
RU - Federazione Russa 1.296
SG - Singapore 1.227
CN - Cina 1.226
IE - Irlanda 795
DE - Germania 566
BR - Brasile 547
SE - Svezia 488
UA - Ucraina 429
VN - Vietnam 407
FR - Francia 397
HK - Hong Kong 275
FI - Finlandia 194
KR - Corea 174
IN - India 149
CA - Canada 78
ZA - Sudafrica 77
BD - Bangladesh 73
TR - Turchia 66
ES - Italia 64
AR - Argentina 53
BE - Belgio 43
CI - Costa d'Avorio 39
NL - Olanda 39
PL - Polonia 35
MX - Messico 34
CZ - Repubblica Ceca 33
NG - Nigeria 31
JP - Giappone 30
IQ - Iraq 29
PK - Pakistan 25
ID - Indonesia 24
IR - Iran 24
AT - Austria 22
CO - Colombia 17
EC - Ecuador 15
PT - Portogallo 15
VE - Venezuela 14
AE - Emirati Arabi Uniti 13
EE - Estonia 13
LT - Lituania 12
AU - Australia 11
JO - Giordania 11
KE - Kenya 11
CH - Svizzera 10
CR - Costa Rica 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
AZ - Azerbaigian 9
TN - Tunisia 9
BO - Bolivia 8
EG - Egitto 8
SK - Slovacchia (Repubblica Slovacca) 8
EU - Europa 7
JM - Giamaica 7
PH - Filippine 7
PY - Paraguay 7
TH - Thailandia 7
MA - Marocco 6
NI - Nicaragua 6
NP - Nepal 6
AL - Albania 5
AM - Armenia 5
CL - Cile 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
MY - Malesia 5
NZ - Nuova Zelanda 5
PR - Porto Rico 5
RO - Romania 5
BG - Bulgaria 4
GR - Grecia 4
HU - Ungheria 4
IL - Israele 4
KZ - Kazakistan 4
SY - Repubblica araba siriana 4
DK - Danimarca 3
ET - Etiopia 3
KW - Kuwait 3
OM - Oman 3
PE - Perù 3
BS - Bahamas 2
BY - Bielorussia 2
DZ - Algeria 2
GD - Grenada 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
LB - Libano 2
LK - Sri Lanka 2
MT - Malta 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
SO - Somalia 2
Totale 23.061
Città #
Southend 1.712
Dallas 1.063
Fairfield 878
Dublin 784
Ashburn 763
Singapore 732
Menlo Park 730
Chandler 554
San Jose 457
Woodbridge 400
Santa Clara 396
Milan 381
Siena 371
Moscow 361
Jacksonville 347
Wilmington 332
Seattle 311
Houston 305
Cambridge 276
Beijing 267
Hong Kong 261
Council Bluffs 242
Ann Arbor 238
Hefei 202
Seoul 168
Princeton 164
Los Angeles 152
New York 131
Ho Chi Minh City 122
The Dalles 122
Nanjing 116
Helsinki 111
Florence 110
Rome 101
Boardman 83
Hanoi 83
Lauterbourg 83
Munich 71
Johannesburg 67
San Mateo 59
Columbus 54
São Paulo 54
Shanghai 52
Buffalo 51
Bengaluru 50
Dearborn 47
London 46
San Diego 46
Fremont 45
Nanchang 44
Brussels 41
Abidjan 39
Izmir 38
Orem 37
Lancaster 34
Shenyang 32
Frankfurt am Main 30
Abuja 29
Figino 28
Málaga 28
Haiphong 27
Atlanta 26
Phoenix 26
Warsaw 26
Chicago 25
Tianjin 25
Da Nang 24
Stockholm 24
Tokyo 23
Hebei 22
Changsha 21
Denver 21
Redwood City 21
Brno 20
Amsterdam 19
Norwalk 19
Brooklyn 18
Chennai 18
Jiaxing 18
Montreal 18
Boston 17
Redondo Beach 17
Vienna 17
Zhengzhou 17
Dong Ket 16
Kunming 16
Rio de Janeiro 16
San Francisco 16
Toronto 16
Belo Horizonte 15
Hangzhou 15
Manchester 15
Poplar 15
Renton 15
Turin 15
Turku 15
Philadelphia 14
Brasília 13
Düsseldorf 13
Mumbai 13
Totale 15.678
Nome #
Chondroptosis in alkaptonuric cartilage 508
A new integrated and interactive tool applicable to inborn errors of metabolism: Application to alkaptonuria 508
Amyloidosis, Inflammation, and Oxidative Stress in the Heart of an Alkaptonuric Patient 434
4-Hydroxyphenylpyruvate Dioxygenase and Its Inhibition in Plants and Animals: Small Molecules as Herbicides and Agents for the Treatment of Human Inherited Diseases 425
Homogentisic acid induces morphological and mechanical aberration of ochronotic cartilage in alkaptonuria 422
Biochemical and proteomic characterization of alkaptonuric chondrocytes 411
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. 389
Histological and Ultrastructural Characterization of Alkaptonuric Tissues 382
Smoothened-antagonists reverse homogentisic acid-induced alterations of Hedgehog signaling and primary cilium length in alkaptonuria 376
Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies 370
Beer promotes differentiation and mineralization of human osteoblastic cells: Role of silicon 370
Establishment of Four New Human Primary Cell Cultures from Chemo-Naïve Italian Osteosarcoma Patients 366
Alkaptonuria is a novel human secondary amyloidogenic disease 364
Inflammatory and oxidative stress biomarkers in alkaptonuria: data from the DevelopAKUre project 358
Angiogenesis in alkaptonuria 355
Yield Determination of Bioethanol Production of Saccharomyces Cerevisiae Metabolic Process by Mathematical Modelling and In-Vivo 13C-NMR 323
Diagnosis of secondary amyloidosis in alkaptonuria 321
Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failure 318
Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria. 314
Cytoskeleton Aberrations in Alkaptonuric Chondrocytes 306
Comparative proteomics in alkaptonuria provides insights into inflammation and oxidative stress 305
Homogentisic acid induces aggregation and fibrillation of amyloidogenic proteins 303
An Introduction to Personalized Nutrition 298
Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria 298
Wild-type wine Saccharomyces cerevisiae as a tool to evaluate the effects on eukaryotic life of locally used herbicides 295
Amyloidosis in alkaptonuria 294
Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes 290
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial 287
Machine learning application for development of a data-driven predictive model able to investigate quality of life scores in a rare disease 286
Secondary amyloidosis in an alkaptonuric aortic valve 282
Interactive alkaptonuria database: investigating clinical data to improve patient care in a rare disease 282
Comparative analysis of the effects of locally used herbicides and their active ingredients on a wild-type wine Saccharomyces cerevisiae strain 277
Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis 277
Machine learning application for patient stratification and phenotype/genotype investigation in a rare disease 276
Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria 276
Antibacterial activity of grape extracts towards cagA positive and cagA negative Helicobacter pylori clinical isolates 273
Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria 272
Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis 272
Oxidative stress and mechanisms of ochronosis in alkaptonuria 270
Mapping phosphoproteins in Neisseria meningitidis serogroup A 267
Saccharomyces cerevisiae as a Tool to Evaluate the Effects of Herbicides on Eukaryotic Life 264
Alkaptonuria 258
Helicobacter pylori: immunoproteomics related to different pathologies 258
Oxidative damage mediated by herbicides on yeast cells 257
Suitability of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment 250
Prevalence of isolated atrial amyloidosis in young patients affected by congestive heart failure 248
Foodomics for human health: current status and perspectives 248
Proteomics and redox-proteomics of the effects of herbicides on a wild-type wine Saccharomyces cerevisiae strain 247
Redox proteomics gives insights into the role of oxidative stress in alkaptonuria 247
Effects of selenium on oxidative damage and antioxidant enzymes of eukaryotic cells: wine Saccharomyces cerevisiae 240
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model 233
In vivo NMR study of yeast fermentative metabolism in the presence of ferric irons 231
Metabolic response to exogenous ethanol in yeast: an in vivo NMR and mathematical modelling approach 227
Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria 226
Supportive use of cyclodextrins as decontamination agents for herbicides 225
Oxidative damage induced by herbicides is mediated by thiol oxidation and hydroperoxides production 220
Membrane Skeletal Protein S-Glutathionylation in Human Red Blood Cells as Index of Oxidative Stress 219
Post-genomics of bone metabolic dysfunctions and neoplasias 215
Cell and tissue models of alkaptonuria 215
Expanding the proteome database of Meningococcus A 214
Saccharomyces cerevisiae as a model in ecotoxicological studies: a post-genomics perspective 211
Personalized nutrition and omics technologies 211
Sub-lethal ethanol exposure enhances viability and ethanol production in Saccharomyces cerevisiae 209
Omics-based technologies for food authentication and traceability 205
Omics Perspectives in Food Science 204
Surfome analysis of a wild-type wine Saccharomyces cerevisiae strain 202
Postgenomics of Neisseria meningitidis: An update 202
Bacterial post-genomics approaches for vaccines development 197
The therapy for Helicobacter pylori eradication 190
Linking protein oxidation to environmental pollutants: redox proteomic approaches 189
Omics and rare diseases: challenges, applications, and future perspectives 184
Post-genomics and skin inflammation 184
Alkaptonuria: From Molecular Insights to a Dedicated Digital Platform 183
Rubus ulmifolius Leaf Extract Inhibits Proliferation of Murine Myeloma Cells 171
Diagnosis of Helicobacter pylori infection 169
Leveraging proteomics in orphan disease research: pitfalls and potential 165
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria 164
The analysis of Neisseria meningitidis proteomes: reference maps and their applications 161
Postgenomics of Neisseria meningitidis for vaccines development 161
Identification of Helicobacter pylori proteins involved in metronidazole resistance by comparative proteomic analysis 160
Post-genomics of Neisseria meningitidis: an update 158
Proteomics in plant research 150
Survey on the recent advances in 4-Hydroxyphenylpyruvate Dioxygenase (HPPD) inhibition by diketone and triketone derivatives and congeneric compounds: structural analysis of HPPD/inhibitor complexes and structure-activity relationship considerations 150
Helicobacter pylori infection and extra-digestive diseases 138
Helicobacter pylori VacA and CagA virulence factors 138
Kinetics of different processes in human ANP amyloid formation 138
Novel identification of expressed genes and functional classification of hypothetical proteins from Neisseria meningitidis serogroup A 131
Models of rare diseases 128
Subclinical ochronosis features in alkaptonuria: a cross-sectional study 128
A Comprehensive In Vitro and In Silico Approach for Targeting 4-Hydroxyphenyl Pyruvate Dioxygenase: Towards New Therapeutics for Alkaptonuria 109
Uncovering proteomic and biochemical alterations in plasma from Lesch–Nyhan disease patients 96
Destabilization of Helix III Initiates Early Serum Amyloid A Misfolding by Exposing Its Amyloidogenic Core 72
Integrated Clinomics and Molecular Dynamics Simulation Approaches Reveal the SAA1.1 Allele as a Biomarker in Alkaptonuria Disease Severity 24
From Waste to Functional Biomicroreactors: Exploration of Wool-Based Stimuli-Triggered Reversible Pickering Emulsions for Transition Metal Catalysis in Water 16
Totale 23.340
Categoria #
all - tutte 65.992
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.992


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.156 0 0 0 121 77 62 83 60 86 193 161 313
2022/20231.822 117 188 236 249 167 340 61 155 167 43 54 45
2023/20241.357 47 30 126 65 66 361 427 38 5 14 48 130
2024/20252.657 64 136 328 136 295 132 128 180 258 115 261 624
2025/20267.152 453 884 886 862 1.364 253 771 172 254 352 198 703
2026/20271.111 284 202 558 67 0 0 0 0 0 0 0 0
Totale 23.340